TRAF1/C5 polymorphism is not associated with pemphigus
K. Mejri
Laboratoire d’Immunologie, Hôpital la Rabta, Tunis, Tunisia
Search for more papers by this authorH. Mbarek
Genhotel-EA3886, Evry & Paris 7 Universities, AP-HP and CHSF Hospitals, AutoCure European Consortium member, 91057 Evry-Genopole, France
Search for more papers by this authorM. Kallel-Sellami
Laboratoire d’Immunologie, Hôpital la Rabta, Tunis, Tunisia
Search for more papers by this authorE. Petit-Teixeira
Genhotel-EA3886, Evry & Paris 7 Universities, AP-HP and CHSF Hospitals, AutoCure European Consortium member, 91057 Evry-Genopole, France
Search for more papers by this authorY. Zerzeri
Laboratoire d’Immunologie, Hôpital la Rabta, Tunis, Tunisia
Search for more papers by this authorO. Abida
Laboratoire d’Immunologie, Hôpital Habib Bourguiba, Sfax, Tunisia
Search for more papers by this authorM. Zitouni
Laboratoire d’Immunologie, Hôpital la Rabta, Tunis, Tunisia
Search for more papers by this authorM. Ben Ayed
Laboratoire d’Immunologie, Hôpital Habib Bourguiba, Sfax, Tunisia
Search for more papers by this authorM. Mokni
Service de Dermatologie, Hôpital la Rabta, Tunis, Tunisia
Search for more papers by this authorB. Fezza
Service de Dermatologie, Hôpital Charles Nicolle, Tunis, Tunisia
Search for more papers by this authorH. Turki
Service de Dermatologie, Hôpital Hédi Chaker, Sfax, Tunisia
Search for more papers by this authorF. Tron
INSERM U519, Institut Fédératif de Recherche Multidisciplinaire sur les Peptides (IFR23), Faculté Mixte de Médecine et de Pharmacie, Rouen, France
Search for more papers by this authorD. Gilbert
INSERM U519, Institut Fédératif de Recherche Multidisciplinaire sur les Peptides (IFR23), Faculté Mixte de Médecine et de Pharmacie, Rouen, France
Search for more papers by this authorH. Masmoudi
Laboratoire d’Immunologie, Hôpital Habib Bourguiba, Sfax, Tunisia
Search for more papers by this authorF. Cornelis
Genhotel-EA3886, Evry & Paris 7 Universities, AP-HP and CHSF Hospitals, AutoCure European Consortium member, 91057 Evry-Genopole, France
Search for more papers by this authorS. Makni
Laboratoire d’Immunologie, Hôpital la Rabta, Tunis, Tunisia
Search for more papers by this authorK. Mejri
Laboratoire d’Immunologie, Hôpital la Rabta, Tunis, Tunisia
Search for more papers by this authorH. Mbarek
Genhotel-EA3886, Evry & Paris 7 Universities, AP-HP and CHSF Hospitals, AutoCure European Consortium member, 91057 Evry-Genopole, France
Search for more papers by this authorM. Kallel-Sellami
Laboratoire d’Immunologie, Hôpital la Rabta, Tunis, Tunisia
Search for more papers by this authorE. Petit-Teixeira
Genhotel-EA3886, Evry & Paris 7 Universities, AP-HP and CHSF Hospitals, AutoCure European Consortium member, 91057 Evry-Genopole, France
Search for more papers by this authorY. Zerzeri
Laboratoire d’Immunologie, Hôpital la Rabta, Tunis, Tunisia
Search for more papers by this authorO. Abida
Laboratoire d’Immunologie, Hôpital Habib Bourguiba, Sfax, Tunisia
Search for more papers by this authorM. Zitouni
Laboratoire d’Immunologie, Hôpital la Rabta, Tunis, Tunisia
Search for more papers by this authorM. Ben Ayed
Laboratoire d’Immunologie, Hôpital Habib Bourguiba, Sfax, Tunisia
Search for more papers by this authorM. Mokni
Service de Dermatologie, Hôpital la Rabta, Tunis, Tunisia
Search for more papers by this authorB. Fezza
Service de Dermatologie, Hôpital Charles Nicolle, Tunis, Tunisia
Search for more papers by this authorH. Turki
Service de Dermatologie, Hôpital Hédi Chaker, Sfax, Tunisia
Search for more papers by this authorF. Tron
INSERM U519, Institut Fédératif de Recherche Multidisciplinaire sur les Peptides (IFR23), Faculté Mixte de Médecine et de Pharmacie, Rouen, France
Search for more papers by this authorD. Gilbert
INSERM U519, Institut Fédératif de Recherche Multidisciplinaire sur les Peptides (IFR23), Faculté Mixte de Médecine et de Pharmacie, Rouen, France
Search for more papers by this authorH. Masmoudi
Laboratoire d’Immunologie, Hôpital Habib Bourguiba, Sfax, Tunisia
Search for more papers by this authorF. Cornelis
Genhotel-EA3886, Evry & Paris 7 Universities, AP-HP and CHSF Hospitals, AutoCure European Consortium member, 91057 Evry-Genopole, France
Search for more papers by this authorS. Makni
Laboratoire d’Immunologie, Hôpital la Rabta, Tunis, Tunisia
Search for more papers by this authorConflicts of interest: none declared.
References
- 1 Tron F, Gilbert D, Joly P et al. Immunogenetics of pemphigus: an update. Autoimmunity 2006; 39: 1–9.
- 2 Kawana S, Geoghegan WD, Jordon RE. Complement fixation by pemphigus antibody II. Complement enhanced detachment of epidermal cells. Clin Exp Immunol 1985; 61: 517–25.
- 3 Plenge RM, Seielstad M, Padyukov L et al. TRAF1-C5 as a risk locus for rheumatoid arthritis—a genomewide study. N Engl J Med 2007; 357: 1199–209.
- 4 Kurreeman FA, Padyukov L, Marques RB et al. A candidate gene approach identifies the TRAF1/C5 region as a risk factor for rheumatoid arthritis. PLoS Med 2007; 4: e278.
- 5 Bastuji-Garin S, Souissi R, Blum L et al. Comparative epidemiology of pemphigus in Tunisia and France: unusual incidence of pemphigus foliaceus in young Tunisian women. J Invest Dermatol 1995; 104: 302–5.
- 6 Dragon-Durey MA, Fremeaux-Bacchi V, Blouin J et al. Restricted genetic defects underlie human C6 deficiency. Clin Exp Immunol 2003; 132: 87–91.
- 7 Jenicek M, Cléroux R. Epidémiologie: Principes, Techniques, Applications, Québec edn. St-Hyacinthe: Edisem, 1982.
- 8 Kurreeman FA, Rocha D, Houwing-Duistermaat J et al. European Consortium on Rheumatoid Arthritis Families. Replication of the tumor necrosis factor receptor-associated factor 1/complement component 5 region as a susceptibility locus for rheumatoid arthritis in a European family-based study. Arthritis Rheum 2008; 58: 2670–4.
- 9 Anhalt GJ, Till GO, Diaz LA et al. Defining the role of complement in experimental pemphigus vulgaris in mice. J Immunol 1986; 137: 2835–40.
- 10 Atkinson JP. Complement system on the attack in autoimmunity. J Clin Invest 2003; 112: 1639–41.
